Potential for Big Data Analysis Using AI in the Field of Clinical Pharmacy

被引:4
作者
Kiryu, Yoshihiro [1 ]
机构
[1] M&B Collaborat Med Corp, Hokuetsu Hosp, 2-20-19 Midori Cho, Niigata 9570018, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2021年 / 141卷 / 02期
关键词
adverse effect; database; machine learning; clinical pharmacy information system; medical informatics computing;
D O I
10.1248/yakushi.20-00196-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Industrial reforms utilizing artificial intelligence (AI) have advanced remarkably in recent years. The application of AI to big data analysis in the medical information field has also been advancing and is expected to be used to find drug adverse effects that cannot be predicted by conventional methods. We have developed an adverse drug reactions analysis system that uses machine learning and data from the Japanese Adverse Drug Event Report (JADER) database. The system was developed using the C# programming language and incorporates the open source machine learning library Accord.Net . Potential analytical capabilities of the system include discovering unknown drug adverse effects and evaluating drug-induced adverse events in pharmaceutical management. However, to apply the system to pharmaceutical management, it is important to examine the characteristics and suitability of the level of AI used in the system and to select statistical methods or machine learning when appropriate. If these points are addressed, there is potential for pharmaceutical management to be individualized and optimized in the clinical setting by using the developed system to analyze big data. The system also has the potential to allow individual healthcare facilities such as hospitals and pharmacies to contribute to drug repositioning, including the discovery of new efficacies, interactions, and drug adverse events.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 27 条
[1]   Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine [J].
Ahmed, Zeeshan ;
Mohamed, Khalid ;
Zeeshan, Saman ;
Dong, Xinqi .
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2020,
[2]  
Akiba S., 2019, KIKAIGAKUSHU ZUKAN, P130
[3]  
Akiba S., 2019, KIKAIGAKUSHU ZUKAN
[4]  
Columbus L., 2019, FORBES MEDIA LL 0327
[5]   Artificial Intelligence for Clinical Trial Design [J].
Harrer, Stefan ;
Shah, Pratik ;
Antony, Bhavna ;
Hu, Jianying .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (08) :577-591
[6]  
Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830
[7]  
IBM Watson Health, HEALTHC PROV SOL MOD
[8]  
Igarashi T., 2018, JPN J DRUG INFORM, V20, P66
[9]   Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions [J].
Inaba, Ichiro ;
Kondo, Yuki ;
Iwasaki, Shinya ;
Tsuruhashi, Satoko ;
Akaishi, Ayano ;
Morita, Kazuya ;
Oniki, Kentaro ;
Saruwatari, Junji ;
Ishitsuka, Yoichi ;
Irie, Tetsumi .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[10]   Artificial intelligence in healthcare: past, present and future [J].
Jiang, Fei ;
Jiang, Yong ;
Zhi, Hui ;
Dong, Yi ;
Li, Hao ;
Ma, Sufeng ;
Wang, Yilong ;
Dong, Qiang ;
Shen, Haipeng ;
Wang, Yongjun .
STROKE AND VASCULAR NEUROLOGY, 2017, 2 (04) :230-243